Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.


Project Scope

This project is to evolve

the Nonclinical

the Nonclinical Study Data Reviewer's Guide (nSDRG), based on comments from a public PHUSE review, plus to adapt it to updates of the FDA Technical Conformance Guide. The project continues to check and align with the SDRG template and guide developed by the Optimizing the Use of Data Standards Working Group for clinical studies.

Preparation of a Study Data Reviewer’s Guide (SDRG) is recommended as an integral part of a CDISC standards-compliant study data submission. The challenge is to operationalise this new documentation requirement efficiently and effectively.

Challenges we seek to answer with this project:

  • Provide a practical template for easy access and use

  • Provide guidance document which describes expected content and options to guide nonclinical SDRG authors.

  • Provide authors with examples, describing how to handle different data situations with SDRG content.

Things we expect to learn along the way:

  • Exploration of ways to generate the nonclinical SDRG and who should do the job.

  • The SDRG is expected to be useful by FDA reviewers. Can it also be useful for other nonclinical study stakeholders?

  • Will the SDRG evolve as systems and processes gain expertise in the new SEND requirements for submission of nonclinical data?



Project Leads

Email

Debra Oetzman

(

, Instem

) (

, Sanofi

)Katie Warren (
Alex Pearce, PHUSE Project Assistant
)
katie@phuseObjectives & DeliverablesTimelines

Maintain the Nonclinical SDRG based on FDA's TCG and any public feedback Q2 2021 Publish nSDRG v 1.2Q2 2022


Status
colourBlue
titleCurrent Status
Q2

2022
  • Published nSDRG v 1.2 
  • 2024

    • Updated version of guide and template based on user feedbackReady for internal deliverables review; checking to see if FDA wants to reviewPresent differences from current version at CSS in June; potential for a Wednesday Webinar topic subsequently. 
    Project currently on hold, resume in Q3 2022





    Published Deliverables

    nSDRG v1.2 

    Version 1.2, 8 April 2022
    Maintaining the Clinical & Nonclinical Study Data Reviewers Guides CSS 2018 Workshop



    Nonclinical SDRG Package

    The Nonclinical SDRG package has been developed to comply with the FDA's Study Data Technical Conformance Guide. The current version of this document can be found at the website:

     

    FDA Data Standards Resources. The nSDRG team continues to monitor FDA's Technical Conformance Guide updates (which occur 2X per year, expected in MAR and OCT) and also public comments received from users of nSDRG. As these new inputs are evaluated, we will post answers in the SEND Implementation Forum, and update the published documents as needed. Stay tuned for update announcements.

    Project Members 

    Organisation Anja MetzgerBayer

    Brett Coupland

    AstraZeneca

    Cathy Roy

    Merck

    Christy Kubin 

    MPI Research

    Daniel Potenta 

    PDS Life Sciences

    Debra Oetzman

    Instem

    Deepika V.G 

    PointCross Life SciencesFlorence Halbert NovartisGitte Frausing Data Standards DecisionsHepei Chen FDAJack Baker Labcorp Jennifer Feldmann EpredaKaren Porter PointCrossKenneth Hershman NovartisKimberley HolichAbbVie

    Project Members 

    Organisation 

    Linda Hunt 

    Merck

    Lindsy Eickhoff 

    Inotiv

    Mandie Rhodes 

    Bristol Myers Squibb

    Mark Carfagna 

    Eli LillyMatthew WhittakerFDAMaureen Rossi RocheMichael Rosentreter BayerNicola Robertson GSKPaul Brown FDARick Thompson Janssen Research & DevelopmentSenthil Palani XybionSteve PolleyGSKSusie Lendal Antvorskov Data Standards DecisionsSoujanya KondaIQVIA Tania Smith LabcorpWilliam Houser Bristol Myers Squib